Inflygent Pharmaceutical AI

Inflygent Pharmaceutical AI Technology Co., Ltd. (hereinafter referred to as "Inflygent Pharmaceutical AI"), officially commenced operations in June 2019, is a start-up company driven by artificial intelligence with the goal of innovative drug development. Inflygent Pharmaceutical AI fully utilizes and continuously develops advanced AI drug discovery technologies in new drug research and development, creating an independent intellectual property AI + new drug R&D platform — PharmaBrainTM. PharmaBrain is a drug discovery system that integrates top expert talent, first-class AI + new drug R&D platforms, and cutting-edge drug design methods. Inflygent Pharmaceutical AI boasts industry-leading success rates in First-in-Class candidate drug development, committed to efficiently and massively developing self-innovated drug varieties while also providing advanced technical services and solutions for pharmaceutical companies' new drug R&D.